BSE filing, NSE: MEDICO. Summary written from the filing by ALFA Finder's alert engine.
Medico Remedies Ltd: key numbers
- Share price
- ₹19.37
- Market cap
- ₹160.7 Cr
- Revenue (annual)
- ₹206.4 Cr
- Net profit (annual)
- ₹13.12 Cr
- P/E (TTM)
- 11.6×Sector 46.1×
- Promoter holding
- 61.38%+0.00% QoQ
- FII holding
- 0.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medico Remedies Ltd
All →Medico Remedies Other Announcement
Medico Remedies Ltd has filed its quarterly shareholding pattern statement for the period ended September 30, 2026. This is a periodic regulatory compliance filing.
Medico Remedies Price Movement Clarification
Medico Remedies confirmed to the exchanges that the recent stock price movement is driven by market conditions and no undisclosed information exists.
Medico Remedies Annual General Meeting
Medico Remedies Ltd held its 32nd Annual General Meeting on September 22, 2026, transacting ordinary and special business, including director re-appointments and remuneration revisions.
Medico Remedies Annual Report
Medico Remedies Ltd has submitted its Annual Report for the financial year 2025-26 and the Notice of its 32nd Annual General Meeting.
Medico Remedies Annual General Meeting
Medico Remedies Limited has issued a notice for its 32nd Annual General Meeting scheduled for September 22, 2026. The meeting agenda includes financial statements and director re-appointments.
Medico Remedies Annual General Meeting
Medico Remedies Limited announced its 32nd Annual General Meeting scheduled for September 22, 2026. The meeting will seek shareholder approval for financial statements and various director appointments.
- Value
- ₹0.10 Cr
Other other announcement announcements
All →Spice Islands Industries Other Announcement
Spice Islands Industries filed a Reg 32 statement reporting no deviation in preferential issue fund utilization for Q3 FY27. The ₹8.70 Crore raise is fully deployed.
Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.
Man Infraconstruction Other Announcement
Man Infraconstruction filed a Reg 32 quarterly statement confirming no deviation in use of preferential-warrant proceeds. No deviation or variation arose for the quarter ended September 30, 2026.
Black Buck Other Announcement
BlackBuck's ICRA monitoring agency report for Q1 FY27 confirms IPO proceeds utilization remains in line with stated objects. No deviation was observed in the quarter.
Raama Finance Other Announcement
Raama Finance appointed M/s. Kumar Gaurav & Co. as statutory auditor for three months effective October 29, 2026. The routine appointment carries no financial impact.
Teja Engineering Industries Other Announcement
Teja Engineering Industries filed a non-applicability certificate for Reg 27(2) Corporate Governance for Q1 FY27. As an NSE Emerge-listed SME, the company is exempt from this periodic disclosure.